Issue 7/2017
Content (12 Articles)
Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease
Carsten Nieder, Dirk De Ruysscher, Laurie E. Gaspar, Matthias Guckenberger, Minesh P. Mehta, Patrick Cheung, Arjun Sahgal
Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy
Hideya Yamazaki, Yusuke Demizu, Tomoaki Okimoto, Mikio Ogita, Kengo Himei, Satoaki Nakamura, Gen Suzuki, Ken Yoshida, Tadayuki Kotsuma, Yasuo Yoshioka, Ryoongjin Oh
Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer
Sang-Won Kim, Mison Chun, Hee-Sug Ryu, Suk-Joon Chang, Tae Wook Kong, Eun Ju Lee, Yong Hee Lee, Young-Taek Oh
General health status of long-term cervical cancer survivors after radiotherapy
Lee Sung Uk, Kim Young Ae, Yoon Young-Ho, Kim Yeon-Joo, Lim Myong Cheol, Park Sang-Yoon, Seo Sang-Soo, Park Ji Eun, Kim Joo-Young
Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer
Ichiro Ogino, Shigenobu Watanabe, Kentaro Sakamaki, Yuka Ogino, Chikara Kunisaki, Kazuo Kimura
Spinal cord constraints in the era of high-precision radiotherapy
Sebastian Zschaeck, Peter Wust, Reinhold Graf, Waldemar Wlodarczyk, Reinhard Schild, Alexander Henry Thieme, Mirko Weihrauch, Volker Budach, Pirus Ghadjar
Patient-reported symptoms during radiotherapy
Philipp Körner, Katja Ehrmann, Johann Hartmannsgruber, Michaela Metz, Sabrina Steigerwald, Michael Flentje, Birgitt van Oorschot
Small bowel protection in IMRT for rectal cancer
Julia Koeck, Katharina Kromer, Frank Lohr, Tobias Baack, Kerstin Siebenlist, Sabine Mai, Sylvia Büttner, Jens Fleckenstein, Frederik Wenz
Hypopharyngeal and upper esophageal ulceration after cervical spine radiotherapy concurrent with crizotinib
Marcus H. Zimmermann, Gabriele Beckmann, Pius Jung, Michael Flentje
Wie lange sollte bis zur Beurteilung des Therapieansprechens nach Radiochemotherapie des Analkarzinoms gewartet werden?
Daniel Martin, Claus Rödel, Emmanouil Fokas
Konsolidierende Lokaltherapie verbessert progressionsfreies Überleben von Patienten mit oligometastasiertem NSCLC
Tobias Finazzi, Matthias Guckenberger
Salvage-Radiotherapie mit antiandrogener Therapie nach Prostatektomie
Gregor Goldner